BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7172502)

  • 1. Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.
    Biondi A; Peri G; Colombo N; Bolis G; Mantovani A
    Clin Exp Immunol; 1982 Sep; 49(3):701-8. PubMed ID: 7172502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
    Bordignon C; Avallone R; Peri G; Polentarutti N; Mangioni C; Mantovani A
    Clin Exp Immunol; 1980 Aug; 41(2):336-42. PubMed ID: 6160006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
    Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
    Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.
    Peri G; Polentarutti N; Sessa C; Mangioni C; Mantovani A
    Int J Cancer; 1981 Aug; 28(2):143-52. PubMed ID: 6172388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of natural killer activity by human bronchoalveolar macrophages.
    Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
    J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity.
    Collota F; Bersani L; Polentarutti N; Mantovani A
    Immunology; 1986 Feb; 57(2):249-53. PubMed ID: 3512426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages as cytotoxic effector cells.
    Lohmann-Matthes ML; Lang H; Sun D
    Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody-defined surface markers of effector cells involved in human monocyte cytotoxicity.
    Villa A; Peri G; Rossi V; Delia D; Mantovani A
    Cell Immunol; 1984 Sep; 87(2):494-503. PubMed ID: 6205772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-restricted effects of human and mouse lymphokines on macrophages.
    Tagliabue A; Mantovani A; Boraschi D; Herberman RB
    Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of tumoricidal activity of human monocytes and macrophages by lymphokines.
    Mantovani A; Dean JH; Jerrells TR; Herberman RB
    Int J Cancer; 1980 Jun; 25(6):691-9. PubMed ID: 14768696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
    Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
    J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-GuĂ©rin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
    Poste G
    Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes.
    Ralph P
    Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
    Poste G; Kirsh R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.